IWP
WST icon

Icon Wealth Partners’s West Pharmaceutical WST Stock Holding History

Icon Wealth Partners’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-16,200
Closed -$6.95M – 349
2021
Q3 		$6.95M Buy
+16,200
New +$6.83M 0.73% 33

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Icon Wealth Partners's WST Position: Q3 2023 in Review

Icon Wealth Partners reduced its West Pharmaceutical (WST) stake by 13% in Q3 2023, selling an estimated $156K and leaving 2,647 shares worth $993K. The position accounts for 0.11% of the portfolio, ranked #120.

Icon Wealth Partners first reported a position in WST in Q4 2017 and has held it in 14 quarters since. The position peaked at $2.59M in Q4 2021. 757 funds tracked by Wall St. Rank hold WST as of Q3 2023.

  • Icon Wealth Partners held 2,647 shares of West Pharmaceutical worth $993K as of Q3 2023.
  • Icon Wealth Partners sold 404 West Pharmaceutical shares in Q3 2023, an estimated $156K.
  • West Pharmaceutical made up 0.11% of Icon Wealth Partners's portfolio in Q3 2023, its #120 holding.
  • Icon Wealth Partners first reported a position in West Pharmaceutical in Q4 2017 and has held it in 14 quarters since.
  • Icon Wealth Partners's West Pharmaceutical position peaked at $2.59M in Q4 2021.
  • 757 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2023.

Based on Icon Wealth Partners's 13F filing for Q3 2023, filed 14 Nov 2023.